AtriCure (ATRC) Tops Q2 EPS by 37c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $61.51 +0.70%
EPS Growth %: -300.0%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
FFBB, HFBL, RUSHA, More
EPS Growth %: -300.0%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
FFBB, HFBL, RUSHA, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.20), $0.37 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $40.8 million versus the consensus estimate of $35.95 million.
2020 Financial Guidance
As previously reported, AtriCure is not providing 2020 financial guidance due to the continued uncertainties from the impact of COVID-19.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ONEOK (OKE) Tops Q3 EPS by 63c; raises guidance
- Baker Hughes Company (BKR) Tops Q3 EPS by 10c
- Rogers (ROG) Tops Q3 EPS by 20c, Misses on Revenue; Offers Q4 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
